Synovial sarcoma-unusual presentation with cerebral hemorrhage

被引:12
作者
Przkora, R
Vogel, P
Ullrich, OW
Knüchel, R
Jauch, KW
Bolder, U
机构
[1] Univ Regensburg, Med Ctr, Dept Surg, D-93053 Regensburg, Germany
[2] Univ Regensburg, Med Ctr, Dept Neurosurg, D-8400 Regensburg, Germany
[3] Univ Regensburg, Med Ctr, Dept Pathol, D-8400 Regensburg, Germany
关键词
synovial sarcoma; metastasis; cerebral hemorrhage; Baker's cyst;
D O I
10.1007/s00402-003-0534-8
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Introduction. Soft-tissue sarcomas account for 1% of all malignancies in adults. Typical symptoms comprise a growing and painless mass. Occasionally, the diagnosis is facilitated by secondaries. Materials and methods. Here we report the first case presented with intracranial hemorrhage caused by a metastasis of a previously unknown synovial sarcoma. The 74-year-old female patient was under anticoagulation for recurrent thrombosis of the right popliteal vein due to compression by the sarcoma, misdiagnosed as Baker`s cyst. The brain metastasis was resected, and after an incisional biopsy of the suspected tumor, which confirmed the diagnosis of a synovial sarcoma, an above knee amputation was performed because of the invasion of the neurovascular structures in the popliteal fossa. Results. The patient died 11 months after the initial event from pulmonary and further brain metastases. Conclusion. Brain metastases are seldom the primary factor in the management of advanced synovial sarcoma. Initially, the primary tumor was thought to be a benign cyst; we therefore recommend a biopsy/excision of lesions greater than 5 cm in size and with growth tendency to allow appropriate treatment.
引用
收藏
页码:376 / 378
页数:3
相关论文
共 16 条
[1]   THE ROLE OF MULTIMODALITY THERAPY IN SOFT-TISSUE SARCOMA [J].
BRENNAN, MF ;
CASPER, ES ;
HARRISON, LB ;
SHIU, MH ;
GAYNOR, J ;
HAJDU, SI .
ANNALS OF SURGERY, 1991, 214 (03) :328-338
[2]  
Brennan Murray F., 1997, P1738
[3]  
CADMAN NL, 1965, CANCER, V18, P613, DOI 10.1002/1097-0142(196505)18:5<613::AID-CNCR2820180510>3.0.CO
[4]  
2-V
[5]  
CHOONG PFM, 1995, INT J ONCOL, V7, P161
[6]   IDENTIFICATION OF NOVEL GENES, SYT AND SSX, INVOLVED IN THE T(X18)(P11.2Q11.2) TRANSLOCATION FOUND IN HUMAN SYNOVIAL SARCOMA [J].
CLARK, J ;
ROCQUES, PJ ;
CREW, AJ ;
GILL, S ;
SHIPLEY, J ;
CHAN, AML ;
GUSTERSON, BA ;
COOPER, CS .
NATURE GENETICS, 1994, 7 (04) :502-508
[7]   Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas - Initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factor [J].
Edmonson, JH ;
Petersen, IA ;
Shives, TC ;
Mahoney, MR ;
Rock, MG ;
Haddock, MG ;
Sim, FH ;
Maples, WJ ;
O'Connor, MI ;
Gunderson, LL ;
Foo, ML ;
Pritchard, DJ ;
Buckner, JC ;
Stafford, SL .
CANCER, 2002, 94 (03) :786-792
[8]   SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma [J].
Kawai, A ;
Woodruff, J ;
Healey, JH ;
Brennan, MF ;
Antonescu, CR ;
Ladanyi, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (03) :153-160
[9]   Synovial sarcoma: A multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity [J].
Lewis, JJ ;
Antonescu, CR ;
Leung, DHY ;
Blumberg, D ;
Healey, JH ;
Woodruff, JM ;
Brennan, MF .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (10) :2087-2094
[10]   Synovial sarcoma: Prognostic significance of tumor size, margin of resection, and mitotic activity for survival [J].
Singer, S ;
Baldini, EH ;
Demetri, GD ;
Fletcher, JA ;
Corson, JM .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (04) :1201-1208